Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
0.6890
-0.0135 (-1.92%)
May 14, 2025, 2:03 PM - Market open
Ocugen Market Cap
Ocugen has a market cap or net worth of $201.21 million as of May 14, 2025. Its market cap has decreased by -38.92% in one year.
Market Cap
201.21M
Enterprise Value
199.17M
1-Year Change
-38.92%
Ranking
Category
Stock Price
$0.69
Market Cap Chart
Since December 3, 2014, Ocugen's market cap has increased from $126.80M to $201.21M, an increase of 58.68%. That is a compound annual growth rate of 4.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 205.30M | -12.45% |
| Dec 31, 2024 | 234.50M | 58.98% |
| Dec 29, 2023 | 147.50M | -48.17% |
| Dec 30, 2022 | 284.60M | -68.60% |
| Dec 31, 2021 | 906.30M | 205.67% |
| Dec 31, 2020 | 296.50M | 3,472.29% |
| Dec 31, 2019 | 8.30M | 50.91% |
| Dec 31, 2018 | 5.50M | -88.84% |
| Dec 29, 2017 | 49.30M | 85.34% |
| Dec 30, 2016 | 26.60M | -42.80% |
| Dec 31, 2015 | 46.50M | -60.86% |
| Dec 31, 2014 | 118.80M | -6.31% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |